130 related articles for article (PubMed ID: 21174063)
1. Leukocyte adhesion-GPCR EMR2 is aberrantly expressed in human breast carcinomas and is associated with patient survival.
Davies JQ; Lin HH; Stacey M; Yona S; Chang GW; Gordon S; Hamann J; Campo L; Han C; Chan P; Fox SB
Oncol Rep; 2011 Mar; 25(3):619-27. PubMed ID: 21174063
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.
Rutkowski MJ; Sughrue ME; Kane AJ; Kim JM; Bloch O; Parsa AT
J Neurooncol; 2011 Nov; 105(2):165-71. PubMed ID: 21503828
[TBL] [Abstract][Full Text] [Related]
3. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer.
Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):467-74. PubMed ID: 17255267
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas.
Ivan ME; Safaee M; Oh T; Clark AJ; Sun MZ; Kim J; Bloch O; Jahangiri A; Phillips JJ; Aghi MK; Parsa AT
J Neurooncol; 2015 Jan; 121(1):53-61. PubMed ID: 25200831
[TBL] [Abstract][Full Text] [Related]
5. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97.
Lin HH; Stacey M; Hamann J; Gordon S; McKnight AJ
Genomics; 2000 Jul; 67(2):188-200. PubMed ID: 10903844
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma.
Grunewald TG; Kammerer U; Kapp M; Eck M; Dietl J; Butt E; Honig A
BMC Cancer; 2007 Oct; 7():198. PubMed ID: 17956604
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
[TBL] [Abstract][Full Text] [Related]
8. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
9. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE
Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160
[TBL] [Abstract][Full Text] [Related]
13. CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas.
Aust G; Steinert M; Schütz A; Boltze C; Wahlbuhl M; Hamann J; Wobus M
Am J Clin Pathol; 2002 Nov; 118(5):699-707. PubMed ID: 12428789
[TBL] [Abstract][Full Text] [Related]
14. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
15. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
Liu TT; Li XF; Wang L; Yang JL
Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
[TBL] [Abstract][Full Text] [Related]
16. Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
Kim GE; Lee JS; Park MH; Yoon JH
PLoS One; 2017; 12(11):e0187635. PubMed ID: 29161296
[TBL] [Abstract][Full Text] [Related]
17. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
[TBL] [Abstract][Full Text] [Related]
18. [Special clinical and follow-up aspects of invasive lobular breast cancer].
Mitze M; Meyer F; Goepel E; Kleinkauf-Houcken A; Jonat W
Geburtshilfe Frauenheilkd; 1991 Dec; 51(12):973-9. PubMed ID: 1794684
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the EGF-TM7 family members CD97 and EMR2 in lipid-laden macrophages in atherosclerosis, multiple sclerosis and Gaucher disease.
van Eijk M; Aust G; Brouwer MS; van Meurs M; Voerman JS; Dijke IE; Pouwels W; Sändig I; Wandel E; Aerts JM; Boot RG; Laman JD; Hamann J
Immunol Lett; 2010 Apr; 129(2):64-71. PubMed ID: 20167235
[TBL] [Abstract][Full Text] [Related]
20. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
